CRONOS
One clinical/eClinical platform with distinct operating paths for Late Phase trials and BA/BE & Early Phase studies.

Connect fragmented clinical and regulatory evidence. Surface what matters. Keep decisions traceable, controlled and human-accountable.
A selection of premier life-sciences organizations from WHPL’s broader client portfolio.
Selected clients shown. WHPL has supported a wider portfolio of life-sciences organizations.
Choose the workflow closest to your responsibility.
One clinical/eClinical platform with distinct operating paths for Late Phase trials and BA/BE & Early Phase studies.
Prioritize review, connect study signals and strengthen central monitoring, oversight and database-lock readiness.
Explore Aegis Agents →Know what changed, what it affects and what must be reviewed across MDR/IVDR claims, evidence, risk and post-market outputs.
Explore Continuous Evidence Control →Prioritize review, connect evidence and improve study-control visibility across the systems your teams already operate.
Lab reconciliation signalReview
Site data trendInspect
Query agingOn track
AI is an enabling capability. The product experience is built around evidence, governance and accountable human decisions.
Keep intelligence connected to the source evidence that supports it.
Keep regulated decisions with accountable experts and controlled review.
Make review states, ownership and decisions visible rather than hidden in disconnected tools.
Connect inputs, outputs, changes and evidence paths for defensible oversight.
Tell us where review, evidence or oversight is breaking down. We will begin with a focused diagnostic—not a generic AI demo.